Back
Relmada Therapeutics Stock Price Chart
Access "King of the Quants" Stock Rating System FREE!
[Claim Your 3 Free Grades Now]
Sell
15
RLMD
Relmada Therapeutics
Last Price:
$0.37
Seasonality Move:
19.8%
7 Day Trial
ALL ACCESS PASS
$
7
Free Access to "King of the Quants" Stock Rating System
[Claim Your 3 Free Grades Now]-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RLMD is experiencing slight selling pressure.
Relmada Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.41 | Sell |
| 20-day SMA: | 0.41 | Sell |
| 50-day SMA: | 1.47 | Sell |
| 200-day SMA: | 2.94 | Sell |
| 8-day EMA: | 0.4 | Sell |
| 20-day EMA: | 0.54 | Sell |
| 50-day EMA: | 1.25 | Sell |
| 200-day EMA: | 2.71 | Sell |
Relmada Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.25 | Sell |
| Relative Strength Index (14 RSI): | 25.59 | Sell |
| Chaikin Money Flow: | -78776 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.36 - 0.44) | Sell |
| Bollinger Bands (100): | (1.06 - 3.66) | Sell |
Relmada Therapeutics Technical Analysis
| Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Relmada Therapeutics Stock
Is Relmada Therapeutics Stock a Buy?
-
Relmada Therapeutics share price is 0.37 while RLMD 8-day simple moving average is 0.41, which is a Sell signal.
-
The stock price of RLMD is 0.37 while Relmada Therapeutics 20-day SMA is 0.41, which makes it a Sell.
-
Relmada Therapeutics 50-day simple moving average is 1.47 while RLMD share price is 0.37, making it a Sell technically.
-
RLMD stock price is 0.37 and Relmada Therapeutics 200-day simple moving average is 2.94, creating a Sell signal.
RLMD Technical Analysis vs Fundamental Analysis
Sell
15
Relmada Therapeutics (RLMD)
is a Sell
Is Relmada Therapeutics a Buy or a Sell?
-
Relmada Therapeutics stock is rated a SellThe current Relmada Therapeutics [RLMD] share price is $0.37. The Score for RLMD is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
Relmada Therapeutics Stock Info
Market Cap:
11.3M
Price in USD:
0.37
Share Volume:
204.3K
Relmada Therapeutics 52-Week Range
52-Week High:
7.22
52-Week Low:
0.34
Sell
15
Relmada Therapeutics (RLMD)
is a Sell
Relmada Therapeutics Share Price Forecast
-
What is the Relmada Therapeutics stock price today?The Relmada Therapeutics stock price is 0.37 USD today.
-
Will RLMD stock go up or go down?Relmada Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Relmada Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Relmada Therapeutics is overvalued.
Is Relmada Therapeutics Stock a Buy?
-
Relmada Therapeutics share price is 0.37 while RLMD 8-day exponential moving average is 0.40, which is a Sell signal.
-
The stock price of RLMD is 0.37 while Relmada Therapeutics 20-day EMA is 0.54, which makes it a Sell.
-
Relmada Therapeutics 50-day exponential moving average is 1.25 while RLMD share price is 0.37, making it a Sell technically.
-
RLMD stock price is 0.37 and Relmada Therapeutics 200-day simple moving average is 2.71, creating a Sell signal.
Fundamental Analysis of Relmada Therapeutics
Is Relmada Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and an increase next year of $0.39 per share.
Technical Analysis of Relmada Therapeutics
Should I short Relmada Therapeutics stock?
-
RLMD Moving Average Covergence Divergence (MACD) indicator is -0.25, suggesting Relmada Therapeutics is a Sell
-
Relmada Therapeutics Relative Strength Index (RSI) is 25.59, which suggest Relmada Therapeutics is oversold
-
The Bollinger Bands (25) for Relmada Therapeutics is (0.36 - 0.44), which suggest Relmada Therapeutics is a Sell
-
The Bollinger Bands (100) for Relmada Therapeutics is (1.06 - 3.66), which suggest Relmada Therapeutics is a Sell
* Relmada Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.